Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
November 04, 2024 07:30 ET
|
Angitia Incorporated Limited
WOODLAND HILLS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for...
Bone Wax Market to Reach $73.0 Million, Globally, by 2033 at 3.2% CAGR: Allied Market Research
October 07, 2024 12:57 ET
|
Allied Analytics LLP
Wilmington, Delaware, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Bone Wax Market by Product (Absorbable Bone Wax and Non-Absorbable Bone Wax), by...
Axial Bone Densitometer Market to Reach $1.0 Billion, Globally, by 2033 at 3.9% CAGR: Allied Market Research
September 27, 2024 09:54 ET
|
Allied Analytics LLP
Wilmington, Delaware, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Axial Bone Densitometer Market by Technology (Dual-Energy X-ray Absorptiometry and...
[Latest] Global Bone and Joint Health Supplement Market Size/Share Worth USD 17.17 Billion by 2032 at a 9.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
January 15, 2024 00:30 ET
|
Custom Market Insights
Austin, TX, USA, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Bone and Joint Health Supplement Market Size, Trends and Insights By Type...
Bone Graft and Substitutes Market will reach to USD 5.78 billion by 2030 : GreyViews
January 03, 2023 15:00 ET
|
GreyViews
Pune India, Jan. 03, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
Animal Intestinal Health Global Market Report 2022: Increased Production of Compound Feed Boosting Growth
October 24, 2022 04:43 ET
|
Research and Markets
Dublin, Oct. 24, 2022 (GLOBE NEWSWIRE) -- The "Animal Intestinal Health Market by Additive (Probiotics, Prebiotics, Phytogenics, Immunostimulants), Livestock (Poultry, Swine, Ruminant, Aquaculture),...
Xtant Medical Holdings, Inc. Reports Third Quarter 2015 Results
November 11, 2015 16:27 ET
|
Xtant Medical Holdings, Inc.
Third Quarter 2015 Consolidated Pro Forma Highlights: Consolidated pro forma revenue increased 6.5% to $20.9 million from $19.6 million in the third quarter of 2014. Excluding OEM revenue,...
Xtant Medical Announces First Surgical Use of OsteoSelect® PLUS DBM Putty
November 03, 2015 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced...